Daniel K. Harris, Ph.D.
Vice President of Pharmaceutical Development and Chemistry, Manufacturing & Controls (CMC)
Daniel joined Lumicell in 2017 as a Principal Scientist. In his current role as Vice President of Pharmaceutical Development and Chemistry, Manufacturing and Controls, Dr. Harris is responsible for the development of Lumicell’s optical imaging agent, LUMISIGHT™, as well as regulatory strategy and preparation of drug-related regulatory filings, including the New Drug Application. Prior to joining Lumicell, Daniel led the chemistry R&D group at QD Vision, a nanomaterials company developing fluorescent materials for the consumer display market and supported the company through its acquisition by Samsung. He earned his doctorate from Massachusetts Institute of Technology, studying in the laboratory of Dr. Moungi Bawendi and developing fluorescent nanomaterials for in vivo imaging, and received a Bachelor of Science in chemical engineering from the University of Southern California. Daniel is an author on 14 academic papers and an inventor on three patents.